Antibody‐dependent cellular cytotoxicity toward neuroblastoma enhanced by activated invariant natural killer T cells

Anti‐ganglioside GD2 antibodies mainly work through antibody‐dependent cellular cytotoxicity (ADCC) and have demonstrated clinical benefit for children with neuroblastoma. However, high‐risk neuroblastoma still has a high recurrence rate. For further improvement in patient outcomes, ways to maximize...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Sci
Päätekijät: Mise, Naoko, Takami, Mariko, Suzuki, Akane, Kamata, Toshiko, Harada, Kazuaki, Hishiki, Tomoro, Saito, Takeshi, Terui, Keita, Mitsunaga, Tetsuya, Nakata, Mitsuyuki, Ikeuchi, Takayuki, Nakayama, Toshinori, Yoshida, Hideo, Motohashi, Shinichiro
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2016
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4814252/
https://ncbi.nlm.nih.gov/pubmed/26749374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12882
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia